Interferon-beta treatment in patients with childhood-onset multiple sclerosis

Y Mikaeloff; T Moreau; M Debouverie; J Pelletier; C Lebrun; O Gout; J M Pedespan; C Van Hulle; P Vermersch; G Ponsot

doi:10.1067/mpd.2001.117004

Interferon-beta treatment in patients with childhood-onset multiple sclerosis

J Pediatr. 2001 Sep;139(3):443-6. doi: 10.1067/mpd.2001.117004.

Authors

Y Mikaeloff¹, T Moreau, M Debouverie, J Pelletier, C Lebrun, O Gout, J M Pedespan, C Van Hulle, P Vermersch, G Ponsot

Affiliation

¹ Department of Neuropediatrics, Saint-Vincent de Paul Hospital, Paris, France.

PMID: 11562627
DOI: 10.1067/mpd.2001.117004

Abstract

We present a report of the use of interferon-beta before 18 years of age in 16 patients with childhood-onset multiple sclerosis. This study demonstrated that the treatment is safe and well tolerated.

MeSH terms

Adjuvants, Immunologic / adverse effects
Adjuvants, Immunologic / therapeutic use*
Adolescent
Child
Female
Humans
Interferon-beta / adverse effects
Interferon-beta / therapeutic use*
Male
Multiple Sclerosis / drug therapy*
Treatment Outcome

Substances

Adjuvants, Immunologic
Interferon-beta